Lusaka

Lusaka is rapidly emerging as a premier pharmaceutical manufacturing hub in Southern Africa, driven by the strategic Lusaka Agenda to enhance regional health security and self-sufficiency.

As a focal point for healthcare innovation, the city hosts a growing cluster of biotechnology initiatives aimed at localizing the production of essential vaccines and biologicals.

The University of Zambia (UNZA) serves as the anchor for academic research, fostering multidisciplinary breakthroughs in infectious diseases and clinical trials through its specialized School of Health Sciences.

Lusaka’s ecosystem is further bolstered by a robust medical device sector, where startups and established firms are streamlining the medical supply chain for high-quality diagnostic equipment.

International investors are increasingly drawn to the city’s favorable regulatory environment and its role as a gateway to the SADC and AfCFTA markets.

Public-private partnerships in the capital are accelerating drug discovery and genomic research, positioning Zambia at the forefront of African precision medicine.

With its integrated approach to life sciences R&D, Lusaka is transforming from a regional distribution point into a sophisticated center for biomedical engineering.

The city’s commitment to digital health and sustainable laboratory infrastructure makes it a vital destination for global life sciences stakeholders.

Currently, Lusaka stands as a testament to how targeted policy and healthcare investment can cultivate a resilient, innovation-led bio-economy.